BOLD · Boundless Bio Inc
United States · RS rating 70 · As of 2026-10-14
| Price | 2.39 USD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 70 / 16 / 47 / 94 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 41 / 37 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +6.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +20.3% |
| Market cap (USD) | $34.1M |